egfr - Robuta Search

https://egfr-calculator.com/ eGFR Calculator Online - Professional Kidney Function Assessment Tool egfr calculator kidney function online professional assessment https://scream.meb.ki.se/egfr-percentiles/ eGFR Percentile Explorer egfr percentile explorer https://ckdstage3.substack.com/p/understanding-egfr-fluctuations-in Impact of Comorbidities, Diet, and Lifestyle on eGFR Fluctuations Insights from the MetaSano Community diet and lifestyle impact comorbidities egfr fluctuations https://umu.diva-portal.org/smash/record.jsf?pid=diva2:1043882&language=en Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants : a nested... https://publications-cnrc.canada.ca/eng/view/object/?id=868d1050-04a2-4892-9811-4cc84fbb6c2e Studies of distribution, location and dynamic properties of EGFR on the cell surface measured by... Studies of distribution, location and dynamic properties of EGFR on the cell surface measured by image correlation spectroscopy https://adisinsight.springer.com/trials/700289044?error=cookies_not_supported&code=de59ac8b-916f-46e4-8084-c393ad620e6d A Phase 1 study of anti-human EGFR (Vectibix sequence) targeted EDVs carrying cytotoxic drug, siRNA... The Tailored EDV study (ENG4) is an open-label feasibility study of a single delivery agent VEDVsPayload containing clinician chosen therapeutic payload(s) https://pubmed.ncbi.nlm.nih.gov/29530932/ Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase... https://pubchem.ncbi.nlm.nih.gov/bioassay/1120257 AID 1120257 - Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based... BioAssay record AID 1120257 submitted by ChEMBL: Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay. https://pubmed.ncbi.nlm.nih.gov/27843640/ Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence Epidermal growth factor receptor (EGFR) plays a key role in tumour evolution, proliferation and immune evasion, and is one of the most important targets for... https://severus.dbmi.pitt.edu/wiki-pi/index.php/pair/view/1956/815 EGFR and CAMK2A - Wiki-Pi Wiki-wiki: a wiki resource centered on human protein-protein interactions egfr wiki pi https://scholars.lib.ntu.edu.tw/entities/publication/d3482153-723a-400a-ac56-09af4dc0bd15 CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR... CCN family protein 2 (CCN2), also known as connective tissue growth factor, is a secreting protein that modulates multiple cellular events. We previously... https://pubmed.ncbi.nlm.nih.gov/36979929/ Amivantamab-Vmjw: A Novel Treatment for Patients with NSCLC Harboring EGFR Exon 20 Insertion... The FDA approval of amivantamab-vmjw, the first bispecific antibody to target the exon20ins mutation, represents an important advancement in the treatment of... https://severus.dbmi.pitt.edu/wiki-MPM/index.php/pair/view/1956/220164 EGFR and DOK6 - Wiki-MPM Wiki-wiki: a wiki resource centered on human protein-protein interactions egfr wiki mpm https://pubchem.ncbi.nlm.nih.gov/bioassay/1803858 AID 1803858 - Wild Type EGFR and Mutant EGFR Kinase Inhibition Test from US Patent US10435400:... BioAssay record AID 1803858 submitted by BindingDB: Wild Type EGFR and Mutant EGFR Kinase Inhibition Test from US Patent US10435400: https://scholars.lib.ntu.edu.tw/entities/publication/74bacc4e-8c9c-40c3-972b-2ed5f5a73696 Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas HER2 is a major proliferative driver in lung cancer. HER2 gene aberrations impact the prognosis of lung adenocarcinoma (ADC). A one-step reverse... clinical outcomes https://egfrcancer.org/ EGFR Positive Lung Cancer Resisters Advocacy Group Mar 26, 2026 - We are a grassroots, patient-driven community, dedicated exclusively to changing EGFR positive lung cancer into a manageable, chronic disease. Email:... lung cancer egfr positive resisters advocacy https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-anti-egfr-anti-il13ralpha2-car-t-cells Definition of autologous anti-EGFR/anti-IL13Ralpha2 CAR T cells - NCI Drug Dictionary - NCI Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes... car t cells definition of https://pubmed.ncbi.nlm.nih.gov/27928026/ AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases Non-small-cell lung cancer patients with activating mutations in epidermal growth factor receptor (EGFR) respond to EGFR tyrosine kinase inhibitor (TKI)... https://data.mendeley.com/datasets/m6hjdjsrgx/4 Pten-NOLC1 Fusion Promotes C-MET and EGFR Signaling in Human Cancers (RNAseq Sample FB174T section... Prostate transcriptome data https://pubchem.ncbi.nlm.nih.gov/bioassay/2057722 AID 2057722 - Selectivity interaction (KinomeScan (DiscoverX)) EUB0001619a EGFR - PubChem BioAssay record AID 2057722 submitted by ChEMBL: Selectivity interaction (KinomeScan (DiscoverX)) EUB0001619a EGFR. aid selectivity interaction discoverx egfr https://data.mendeley.com/datasets/dsg55p75pr/6 Pten-NOLC1 Fusion Promotes C-MET and EGFR Signaling in Human Cancers (RNAseq Sample D006) -... Prostate transcriptome data https://portal.research.lu.se/en/publications/antagonism-of-egfr-and-her3-enhances-the-response-to-inhibitors-o/ Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in... https://www.mdpi.com/2072-6694/13/18/4685 Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer Prolactin receptor (PRLR) and epidermal growth factor receptor (EGFR/ERBB) signaling pathways activated by prolactin (PRL) and epidermal growth factor (EGF),... signaling pathways crosstalk egfr https://pubmed.ncbi.nlm.nih.gov/25173978/ EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation Hepatocellular carcinoma (HCC) is a frequent cancer with limited treatment options and poor prognosis. Tumorigenesis has been linked with macrophage-mediated... https://pubmed.ncbi.nlm.nih.gov/31466227/ Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR... Some commonly available patient or disease characteristics may be associated with progression-free survival (PFS) and overall survival (OS) in EGFR-mutant... small cell lung cancer https://data.mendeley.com/datasets/53wrc86y6s/1 Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous... Supplementary Information for manuscript "Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with... https://digital.library.adelaide.edu.au/items/b5d7fcf3-5a75-476b-8f94-69562835a1ca Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal... Background: Monoclonal antibodies (mAbs) targeting the epidermal growth factor receptor (EGFR) prolong survival in metastatic colorectal cancer (mCRC) Kirsten... https://pmc.ncbi.nlm.nih.gov/articles/PMC3128700/ Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated... Epidermal growth factor receptor inhibitors (EGFRI) produce various dermatologic side effects in the majority of patients, and guidelines are crucial for the... clinical practice guidelines prevention and treatment for the https://pure.psu.edu/en/publications/nfkb-hyperactivation-causes-invasion-of-esophageal-squamous-cell-/ NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression... squamous cell carcinoma https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-gc1118 Definition of anti-EGFR monoclonal antibody GC1118 - NCI Drug Dictionary - NCI Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes... definition of monoclonal antibody egfr nci drug https://connect.mayoclinic.org/discussion/curious-about-test-results/ Curious about eGFR test results | Mayo Clinic Connect curious about test results mayo clinic egfr connect https://pubmed.ncbi.nlm.nih.gov/33641655/?dopt=Abstract 20(S)-Ginsenoside Rg3 Inhibits Lung Cancer Cell Proliferation by Targeting EGFR-Mediated... Lung cancer is the leading cause of cancer death in the world and classified into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). As... https://pubmed.ncbi.nlm.nih.gov/36497413/ Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma? Glioblastoma is the most common form of high-grade glioma in adults and has a poor survival rate with very limited treatment options. There have been no... https://pubmed.ncbi.nlm.nih.gov/31138260/ Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts... Our results identify a combination between osimertinib and pemetrexed or cisplatin potentially useful in the treatment of EGFR-mutated NSCLC patients, which... third generation egfr inhibitor osimertinib https://scholars.lib.ntu.edu.tw/entities/publication/e2e5230e-c080-47d3-9c75-43bdf7e66a1d Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung... Lung cancer remains the primary cause of cancer-related mortality worldwide. Several treatment modalities are available for lung cancer, including surgery,... https://data.mendeley.com/datasets/nk6mp9ydfk/4 Pten-NOLC1 Fusion Promotes C-MET and EGFR Signaling in Human Cancers (RNAseq Sample PR375T section... Prostate transcriptome data https://pubmed.ncbi.nlm.nih.gov/26439264/?dopt=Abstract Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase... In keeping with the effect on NKG2D expression, Gemcitabine enhanced NK cell-mediated cytotoxicity while Gefitinib attenuated NK cell killing in NSCLC cells. of the https://pubmed.ncbi.nlm.nih.gov/27089454/ Skin Barrier Defects Caused by Keratinocyte-Specific Deletion of ADAM17 or EGFR Are Based on Highly... Keratinocyte-specific deletion of ADAM17 in mice impairs terminal differentiation of keratinocytes leading to severe epidermal barrier defects. Mice deficient... https://iris.cnr.it/handle/20.500.14243/332451 Aptamer-mediated impairment of EGFR-integrin alpha v beta 3 complex inhibits vasculogenic mimicry... https://nrc-publications.canada.ca/fra/voir/objet/?id=7137e524-ba4b-422f-ad3c-d288f0c5a9a5 Camelid single-domain antibodies raised by DNA immunization are potent inhibitors of EGFR signaling... Camelid single-domain antibodies raised by DNA immunization are potent inhibitors of EGFR signaling https://pubchem.ncbi.nlm.nih.gov/bioassay/1119829 AID 1119829 - Inhibition of EGF-induced EGFR-mediated ERK phosphorylation in human A431 cells after... BioAssay record AID 1119829 submitted by ChEMBL: Inhibition of EGF-induced EGFR-mediated ERK phosphorylation in human A431 cells after 1 hr by immunoblotting... https://medicine.yale.edu/cancer/research/excellence/lung/projects/proj2/ Project 2: Mechanism-based approaches to counter TKI resistance in EGFR mutant lung cancer | Yale... Targeted therapies have completely transformed the landscape for diagnosis and treatment of metastatic lung cancer. Despite this success, targeted therapies are https://pubmed.ncbi.nlm.nih.gov/35326725/ Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The... The decrease in both CTCs and ctDNA occurring early during osimertinib treatment is predictive of better outcome, implying that liquid biopsy monitoring may be... https://severus.dbmi.pitt.edu/wiki-MPM/index.php/pair/view/1956/1839 EGFR and HBEGF - Wiki-MPM Wiki-wiki: a wiki resource centered on human protein-protein interactions egfr wiki mpm https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-her2-her3-monoclonal-antibody-mixture-sym013 Definition of anti-EGFR/HER2/HER3 monoclonal antibody mixture Sym013 - NCI Drug Dictionary - NCI Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes... https://pubmed.ncbi.nlm.nih.gov/35724798/ Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had... Befotertinib of 75 to 100 mg has satisfying efficacy and manageable toxicity in patients with locally advanced or metastatic NSCLC harboring T790M mutation... https://pubchem.ncbi.nlm.nih.gov/bioassay/2050542 AID 2050542 - Selectivity interaction (KinomeScan (DiscoverX)) EUB0000666a EGFR - PubChem BioAssay record AID 2050542 submitted by ChEMBL: Selectivity interaction (KinomeScan (DiscoverX)) EUB0000666a EGFR. aid selectivity interaction discoverx egfr https://antibodies.cancer.gov/detail/CPTC-EGFR-13 The Clinical Proteomic Technologies for Cancer | Details for CPTC-EGFR-13 Details for CPTC-EGFR-13 clinical proteomic technologies cancer details https://pubmed.ncbi.nlm.nih.gov/20573926/ Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR First-line gefitinib for patients with advanced non-small-cell lung cancer who were selected on the basis of EGFR mutations improved progression-free survival,... small cell lung cancer https://uknowledge.uky.edu/markey_facpub/463/ "An Agrin-YAP/TAZ Rigidity Sensing Module Drives EGFR-Addicted Lung Tum" by Reza Bayat Mokhtari,... Despite epidermal growth factor receptor (EGFR) is a pivotal oncogene for several cancers, including lung adenocarcinoma (LUAD), how it senses extracellular... https://www.nice.org.uk/guidance/ta855 Mobocertinib for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung... NICE has withdrawn this guidance. Takeda will stop marketing mobocertinib (Exkivity) and its marketing authorisation has been withdrawn https://adisinsight.springer.com/trials/700353011?error=cookies_not_supported&code=85210300-d5c1-44fd-9fc8-816da5bba207 Phase 1 open-label, multi-center clinical study of SMET12 in patients with EGFR-positive advanced... This phase 1 open-label multi-center clinical study will evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of SMET12 in patients https://scholars.lib.ntu.edu.tw/entities/project/b7fab043-4681-4b65-9c76-3f3dbdbed973 The Difference between Epidermal Growth Factor Receptor (EGFR) Mutation Positive and Negative Small... the difference between epidermal growth factor https://repository.arizona.edu/handle/10150/657599 Elevating EGFR-MAPK program by a nonconventional Cdc42 enhances intestinal epithelial survival and... https://pubmed.ncbi.nlm.nih.gov/25806150/ Advances on EGFR mutation for lung cancer Patients with advanced non-small-cell lung cancer (NSCLC) and somatic activating mutations of the tyrosine kinase (TK) domain of the epidermal growth factor... advances egfr mutation lung cancer https://data.mendeley.com/datasets/f3ymxwc9yv/5 Pten-NOLC1 Fusion Promotes C-MET and EGFR Signaling in Human Cancers (RNAseq Sample 998741T section... Prostate transcriptome data https://pubmed.ncbi.nlm.nih.gov/39089004/ Befotertinib for patients with pretreated EGFR T790M mutated locally advanced or metastatic NSCLC:... Befotertinib demonstrated a more profound OS benefit compared to other 3rd-generation EGFR TKI, despite that cross trial data comparison should be interpreted... https://pubchem.ncbi.nlm.nih.gov/bioassay/2051447 AID 2051447 - Selectivity interaction (KinomeScan (DiscoverX)) EUB0000699a EGFR - PubChem BioAssay record AID 2051447 submitted by ChEMBL: Selectivity interaction (KinomeScan (DiscoverX)) EUB0000699a EGFR. aid selectivity interaction discoverx egfr https://experts.arizona.edu/en/publications/deoxycholic-acid-mediates-non-canonical-egfr-mapk-activation-thro/ Deoxycholic acid mediates non-canonical EGFR-MAPK activation through the induction of calcium... https://pubchem.ncbi.nlm.nih.gov/bioassay/1795051 AID 1795051 - EGFR kinase assay from US Patent US9670213: "Pteridine ketone derivative and... BioAssay record AID 1795051 submitted by BindingDB: EGFR kinase assay from US Patent US9670213: https://pubmed.ncbi.nlm.nih.gov/38638860/ Efficacy of befotertinib in non-small cell lung cancer harboring uncommon compound EGFR mutations... The discovery of epidermal growth factor receptor (EGFR) somatic mutations and the availability of tyrosine kinase inhibitors (TKIs) as targeted therapies have... small cell lung cancer https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1129629/full Frontiers | The novel EGFR mutations (p.E746_S752delinsI, p.T751_I759delinsG, p.L747_S752delinsAA)... Epidermal growth factor receptor (EGFR) is an established driver gene in non-small cell lung cancer (NSCLC) and the common Exon 19 del mutation (p.E746_A750 ... the novel https://pubmed.ncbi.nlm.nih.gov/33282740/ High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With... Bone metastatic NSCLC patients with EGFR mutated disease, treated with EGFR TKIs, have a relatively long survival expectancy and are at high risk to develop... https://africarticles.blogspot.com/2017/11/new-data-show-benefit-of-tagrisso-in.html Africa Articles: New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell... Phase III FLAURA trial demonstrates 52% risk reduction of CNS disease progression or death in patients treated with Tagrisso (osimertinib) ... https://research-portal.uu.nl/en/activities/clathrin-dependent-endocytosis-and-degradation-of-egfr-by-vhh-ind-5/ Clathrin-dependent endocytosis and degradation of EGFR by VHH-induced receptor clusering - Utrecht... https://severus.dbmi.pitt.edu/wiki-pi/index.php/pair/view/1956/214 EGFR and ALCAM - Wiki-Pi Wiki-wiki: a wiki resource centered on human protein-protein interactions egfr alcam wiki pi https://portal.research.lu.se/en/publications/antagonism-of-egfr-and-her3-enhances-the-response-to-inhibitors-o/fingerprints/ Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in... https://pubmed.ncbi.nlm.nih.gov/33988036/ Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving... https://inventions.techventures.columbia.edu/technologies/therapy-for-egfr-mutant-lung--CU22193 Therapy for EGFR-mutant lung cancer Targeting RA signaling to suppress brain relapse in EGFR-mutant lung cancer, boosting TKIs and preventing metastasis. therapy egfr mutant lung cancer https://wwwn.cdc.gov/kdss/detail.aspx?Qnum=Q185 CDC Surveillance System: All-Cause Mortality by eGFR, Including Dialysis and Transplant Patients All-Cause Mortality by eGFR, Including Dialysis and Transplant Patients https://about.uq.edu.au/experts/project/58945 The role of EGFR-CDCP1 axis in the treatment of cholangiocarcinoma | Project | UQ Experts the role https://scholars.duke.edu/publication/1054215 Scholars@Duke publication: Afatinib induces apoptosis in NSCLC without EGFR mutation through... https://pmc.ncbi.nlm.nih.gov/articles/PMC11726021/ Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic... Zongertinib, a covalent HER2 inhibitor, is active in HER2-driven preclinical models and patients and effectively targets HER2 oncogenic signaling while sparing... https://www.semanticscholar.org/topic/EGFR-T790M-Inhibitor-PF-06747775/2727832 EGFR T790M Inhibitor PF-06747775 | Semantic Scholar An orally available inhibitor of the epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic activity. EGFR T790M inhibitor... egfr inhibitor pf semantic scholar https://pubmed.ncbi.nlm.nih.gov/39544299/ Editorial: Advances in the use of EGFR TKIs in the treatment of NSCLC Editorial: Advances in the use of EGFR TKIs in the treatment of NSCLC in the editorial advances use egfr https://pubs.rsc.org/en/Content/ArticleLanding/2020/TB/D0TB00589D A circulating tumor cell-based digital assay for the detection of EGFR T790M mutation in advanced... Determining the status of epidermal growth factor receptor (EGFR) T790M mutation is crucial for guiding further treatment intervention in advanced non-small... https://pubmed.ncbi.nlm.nih.gov/33040673/ Classical versus non-classical EGFR mutations: Erlotinib response and impact of renal insufficiency This research showed OS in patients with and without RI was comparable. Although not statistically significant, PFS in patients with classical mutation was... https://scholars.lib.ntu.edu.tw/entities/publication/ec2363fa-1365-445a-8188-e0c9a58a14ef Identification of tumor suppressors and EGFR-TKI resistance genes by systemic approaches tumor suppressors https://pubmed.ncbi.nlm.nih.gov/35849035/?otool=flbhsflib&holding=flbhsflib Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized... Interim analysis demonstrated no OS benefit for depatux-m in treating EGFR-amp newly diagnosed GBM. No new important safety risks were identified. newly diagnosed https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/symptoms-diagnosis/biomarker-testing/egfr EGFR and Lung Cancer | American Lung Association A mutation in the EGFR gene is one biomarker that physicians look for in non-small cell lung cancer. lung cancer egfr american association https://www.thermofisher.com/antibody/product/Phospho-EGFR-Tyr845-Antibody-Polyclonal/44-784G Phospho-EGFR (Tyr845) Polyclonal Antibody | Invitrogen (44-784G) Detect Phospho-EGFR (Tyr845) in WB, ICC/IF, ELISA, Flow, IHC. Reacts with Rabbit. Cited in 12 publications. Catalog # 44-784G polyclonal antibody phospho egfr invitrogen https://scholars.uky.edu/en/publications/fam83b-mediates-egfr-and-ras-driven-oncogenic-transformation/ FAM83B mediates EGFR- and RAS-driven oncogenic transformation - University of Kentucky transformation university egfr ras https://www.prnewswire.com/news-releases/epidermal-growth-factor-receptor-egfr-inhibitors-market-40-of-growth-to-originate-from-north-america-technavio-302130137.html Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, 40% of Growth to Originate from North... /PRNewswire/ -- The global epidermal growth factor receptor (EGFR) inhibitors market size is estimated to grow by USD 8.401 billion from 2024 to 2028,... epidermal growth factor https://pubmed.ncbi.nlm.nih.gov/39444426/ BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of... https://pubmed.ncbi.nlm.nih.gov/26958510/ Concomitant EGFR mutations/ALK rearrangements: beyond a simple dual target Concomitant EGFR mutations/ALK rearrangements: beyond a simple dual target egfr mutations alk rearrangements beyond https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1472545/full Frontiers | Application of disitamab vedotin in the multiline treatment of EGFR mutation-positive... ObjectiveTo explore the efficacy of c in the multiline treatment of late-stage lung adenocarcinoma with Her-2 overexpression and epidermal growth factor rece... in the https://pubmed.ncbi.nlm.nih.gov/38012986/ Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC Our real-world multicenter analysis revealed that amivantamab is a potentially effective treatment option for patients with EGFR mutations outside of exon 20... efficacy and safety real world https://pubmed.ncbi.nlm.nih.gov/30831205/ Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung... BRAF fusion is a mechanism of AR to EGFR TKI therapy in approximately 2% of patients. Combined inhibition of EGFR and MEK (with osimertinib and trametinib) or... https://amsdottorato.unibo.it/id/eprint/11432/ Deciphering the role of IL-1 signaling as an escape pathway in EGFR-dependent head & neck squamous... https://dspace.mit.edu/handle/1721.1/97977?show=full Elucidating the role of the EGFR-family members in cell motility through the use of novel... https://adisinsight.springer.com/drugs/800087215?error=cookies_not_supported&code=378df6ae-76c8-4cfb-a918-0f828e812325 ABK EGFR 1 - AdisInsight ABK EGFR 1 is small molecule and fourth generation EGFR C797S mutation inhibitor being developed by Abbisko Therapeutics for treatment of cancer. The abk egfr adisinsight https://pubchem.ncbi.nlm.nih.gov/bioassay/1804197 AID 1804197 - High Throughput EGFR Biochemical Assay from US Patent US10577352: "Cot modulators and... BioAssay record AID 1804197 submitted by BindingDB: High Throughput EGFR Biochemical Assay from US Patent US10577352: https://data.mendeley.com/datasets/w56kvp2nfh/4 Pten-NOLC1 Fusion Promotes C-MET and EGFR Signaling in Human Cancers (RNAseq Sample KB170T section... Prostate transcriptome data https://portal.fis.tum.de/en/publications/kras-above-and-beyond-egfr-in-pancreatic-cancer/ KRAS above and beyond - EGFR in pancreatic cancer - Technical University of Munich above and beyond https://drive.google.com/file/d/1nE7DR9Yx12PF3Vsnt-xstHAdldoXrK0F/view?usp=share_link OPS029 KPMP eGFR Data Dictionary_v20230315.pdf - Google Drive data dictionary egfr pdf google drive https://egfrcancer.us12.list-manage.com/subscribe?u=b88efc3db7ed0c4016988ad5f&id=bdf1b7d6cb EGFR Resisters EGFR Resisters Email Forms egfr resisters https://www.cancer.gov/publications/dictionaries/cancer-terms/def/egfr-inhibitor Definition of EGFR inhibitor - NCI Dictionary of Cancer Terms - NCI NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine. definition of egfr inhibitor nci dictionary cancer https://pubs.rsc.org/en/content/articlelanding/2012/md/c2md20017a Superiority of a novel EGFR targeted covalent inhibitor over its reversible counterpart in... Recently, the importance of targeted covalent inhibitors in addressing potency, selectivity and drug resistance has become of great interest, especially in the... targeted covalent inhibitor https://data.mendeley.com/datasets/357f736283/5 Pten-NOLC1 Fusion Promotes C-MET and EGFR Signaling in Human Cancers (RNAseq Sample D000 section 1... Prostate transcriptome data https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01479/full Frontiers | Targeting Immunometabolism Mediated by CD73 Pathway in EGFR-Mutated Non-small Cell Lung... Despite the relevant antitumor efficacy of immunotherapy in advanced non-small cell lung cancer (NSCLC), the results in patients whose cancer harbours activa...